20.01.2015 Views

Introduction to Enzyme and Coenzyme Chemistry - E-Library Home

Introduction to Enzyme and Coenzyme Chemistry - E-Library Home

Introduction to Enzyme and Coenzyme Chemistry - E-Library Home

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

76 Chapter 4<br />

Table 4.3 Group speciWc reagents for active site amino acid modiWcation.<br />

Amino acid Group modiWed Reagent ModiWcation reaction<br />

Cysteine S Iodoacetate, iodoacetamide Alkylation<br />

DTNB<br />

p-Hydroxymercuribenzoate<br />

Disulphide formation<br />

Metal complexation<br />

Histidine N Diethyl pyrocarbonate Acylation<br />

Lysine N Succinic anhydride Acylation<br />

Arginine N Phenylglyoxal Heterocycle formation<br />

Asp, Glu O EDC (water-soluble carbodi-imide) þ amine Amide formation<br />

Tyrosine O Tetranitromethane Nitration<br />

Tryp<strong>to</strong>phan Indole N-bromosuccinimide Oxidation<br />

DTNB, 5,5 0 -dithiobis-(2-nitrobenzoic acid); EDC, 1-ethyl-3-(3-dimethylaminopropyl)carbodi-imide.<br />

active site residue. The enzyme is then irreversibly inactivated, since the active<br />

site is blocked. The advantage of this method over the group speciWc reagents<br />

mentioned above is that aYnity labelling is more selective in its site of action,<br />

due <strong>to</strong> the precise positioning of the substrate analogue at the enzyme active<br />

site. One example of this method is the inactivation of the serine proteases<br />

by chloromethyl ke<strong>to</strong>ne substrate analogues, which will be described in<br />

Section 5.2.<br />

If a successful irreversible inhibi<strong>to</strong>r is found, the site of action of the aYnity<br />

label can be determined using a radiolabelled inhibi<strong>to</strong>r as shown in Figure 4.29.<br />

The enzyme inactivated with labelled inhibi<strong>to</strong>r contains a modiWed active site<br />

E + I*<br />

irreversible<br />

inhibition<br />

E-I*<br />

protease<br />

I*<br />

HPLC<br />

purification<br />

protein sequence<br />

peptide sequence<br />

..K F D A L H S M Y V..<br />

D A L * S M Y<br />

peptide<br />

sequencing<br />

Figure 4.29 IdentiWcation of an active site residue by peptide mapping. HPLC, high-performance<br />

liquid chroma<strong>to</strong>graphy.<br />

I*

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!